Sterneck Capital Management’s GSK GSK Stock Holding History

Sterneck Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-16,835	Closed	-$822K	–	111
2018 Q1	$822K	Sell	16,835 -1,266	-7%	-$59K	0.48%	60
2017 Q4	$803K	Sell	18,101 -3,077	-15%	-$142K	0.48%	61
2017 Q3	$1.07M	Buy	21,178 +3,524	+20%	+$179K	0.62%	53
2017 Q2	$952K	Sell	17,654 -60,354	-77%	-$3.22M	0.57%	55
2017 Q1	$4.11M	Sell	78,008 -13,845	-15%	-$702K	2.44%	8
2016 Q4	$4.42M	Sell	91,853 -6,804	-7%	-$336K	2.84%	7
2016 Q3	$5.32M	Sell	98,657 -2,850	-3%	-$156K	3.54%	2
2016 Q2	$5.5M	Buy	101,507 +11,479	+13%	+$605K	3.66%	2
2016 Q1	$4.56M	Buy	90,028 +7,002	+8%	+$349K	3.21%	6
2015 Q4	$4.19M	Buy	83,026 +9,107	+12%	+$464K	2.67%	7
2015 Q3	$3.55M	Buy	73,919 +4,415	+6%	+$230K	2.33%	9
2015 Q2	$3.62M	Sell	69,504 -444	-0.6%	-$25K	1.99%	13
2015 Q1	$4.04M	Sell	69,948 -6,303	-8%	-$361K	2.17%	11
2014 Q4	$4.07M	Buy	76,251 +4,248	+6%	+$238K	2.42%	8
2014 Q3	$4.14M	Buy	+72,003	New	+$4.41M	2.48%	7

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Sterneck Capital Management's GSK Position: Q2 2018 in Review

Sterneck Capital Management sold out of GSK (GSK) in Q2 2018, closing a stake of 16,835 shares — an estimated $822K sold.

Sterneck Capital Management first reported a position in GSK in Q3 2014 and held it in 15 quarters. The position peaked at $5.5M in Q2 2016. 787 funds tracked by Wall St. Rank hold GSK as of Q2 2018.

Sterneck Capital Management reported no remaining GSK position as of Q2 2018 after selling out during the quarter.
Sterneck Capital Management sold 16,835 GSK shares in Q2 2018, an estimated $822K.
Sterneck Capital Management first reported a position in GSK in Q3 2014 and held it in 15 quarters.
Sterneck Capital Management's GSK position peaked at $5.5M in Q2 2016.
787 funds tracked by Wall St. Rank held GSK as of Q2 2018.

Based on Sterneck Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.